Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
Mar. 31, 2022 |
Mar. 31, 2021 |
|
REVENUES | ||||
TOTAL REVENUES | $ 11,029 | $ 36,974 | $ 21,646 | $ 61,365 |
COST OF GOODS SOLD | 5,409 | 10,762 | 11,095 | 20,355 |
GROSS PROFIT (LOSS) | 5,620 | 26,212 | 10,551 | 41,010 |
OPERATING EXPENSES | ||||
Salaries and payroll taxes | 119,950 | 40,578 | 190,075 | 101,051 |
Professional fees | 193,320 | 58,192 | 366,397 | 58,477 |
General and administrative | 17,163 | 14,707 | 29,846 | 31,239 |
Software development | 13,706 | 15,538 | 29,385 | 47,672 |
Selling expense | 2,549 | 165 | 4,889 | 2,380 |
TOTAL OPERATING EXPENSES | 346,688 | 129,180 | 620,592 | 240,819 |
OPERATING LOSS | (341,068) | (102,968) | (610,041) | (199,809) |
OTHER INCOME (EXPENSE) | ||||
Loss on contingency liability | (400,000) | (400,000) | ||
Gain on PPP loan forgiveness | 24,148 | |||
Amortization debt discount | (87,683) | (87,683) | ||
Interest expense | (11,481) | (784) | (16,940) | (1,586) |
Interest expense - related parties | (859) | (1,406) | (2,296) | (2,522) |
Interest income | 5 | 5 | ||
TOTAL OTHER INCOME (EXPENSE) | (500,018) | (2,190) | (482,766) | (4,108) |
LOSS BEFORE INCOME TAXES | (841,086) | (105,158) | (1,092,807) | (203,917) |
Provision for income taxes | ||||
NET LOSS | $ (841,086) | $ (105,158) | $ (1,092,807) | $ (203,917) |
NET LOSS PER SHARE: | ||||
Basic and diluted net loss per share | $ (0.12) | $ (0.31) | ||
Basic and diluted weighted average number of common shares outstanding | 7,086,416 | 3,504,272 | ||
Insurance Revenue [Member] | ||||
REVENUES | ||||
TOTAL REVENUES | $ 14,887 | $ 72,999 | $ 38,770 | $ 136,228 |
Rental Revenue [Member] | ||||
REVENUES | ||||
TOTAL REVENUES | 29,799 | 175,752 | 64,297 | 329,325 |
Initial Fee Revenue [Member] | ||||
REVENUES | ||||
TOTAL REVENUES | 11,289 | 4,126 | 20,364 | |
Miscellaneous [Member] | ||||
REVENUES | ||||
TOTAL REVENUES | 1,827 | 1,480 | 4,727 | 7,346 |
Vehicle Owner Share [Member] | ||||
REVENUES | ||||
TOTAL REVENUES | (24,099) | (153,627) | (62,889) | (295,885) |
Driver And Dealer Insurance Cost [Member] | ||||
REVENUES | ||||
TOTAL REVENUES | $ (11,385) | $ (70,919) | $ (27,385) | $ (136,013) |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of interest expense classified as other. No definition available.
|
X | ||||||||||
- Definition Amount of interest expense incurred on a debt or other obligation to related party. No definition available.
|
X | ||||||||||
- Definition Amount of interest income earned from interest bearing assets classified as other. No definition available.
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Expenses recognized in the period that are directly related to the selling and distribution of products or services. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|